Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic × Immunoenzyme Techniques × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 4 Breast Neoplasms 4 Breast Neoplasms, Male 3 Sarcoma 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Kidney Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Leukemia 1 Hepatitis C 1 Head and Neck Neoplasms 1 Gliosarcoma 1

Interventions

fludarabine phosphate 22 Mycophenolic Acid 16 Whole-Body Irradiation 15 Peripheral Blood Stem Cell Transplantation 13 Cyclophosphamide 11 Tacrolimus 10 Cyclosporine 10 Antilymphocyte Serum 9 Cyclosporins 8 Busulfan 8 fludarabine 7 Rituximab 7 Methotrexate 5 Sirolimus 4 Melphalan 4 Filgrastim 3 Cytarabine 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 pegfilgrastim 2 ibrutinib 2 Thiotepa 2 Oxaliplatin 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2 Darbepoetin alfa 2 Clofarabine 2 selinexor 1 sargramostim 1 ofatumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡